Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H11NO6P2 |
| Molecular Weight | 267.1129 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OP(O)(=O)C(CC1=NC=CC=C1)P(O)(O)=O
InChI
InChIKey=NGMZSXZBZNXBGX-UHFFFAOYSA-N
InChI=1S/C7H11NO6P2/c9-15(10,11)7(16(12,13)14)5-6-3-1-2-4-8-6/h1-4,7H,5H2,(H2,9,10,11)(H2,12,13,14)
| Molecular Formula | C7H11NO6P2 |
| Molecular Weight | 267.1129 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Piridronic acid is pyridinyl bisphosphonate. It is the bone calcium metabolism regulator. Piridronic acid was used for the treatment of osteoporosis. It is the human farnesyl pyrophosphate synthase inhibitor. When expressed on an actual or anticipated clinical dose basis for osteoporosis piridronic acid may have a greater potential for inducing gastric damage than do pyridinyl bisphosphonates. Piridronic acid induced significantly more antral damage than risedronate and a greater number of lesions compared to pamidronate and risedronate.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. | 2008-04-10 |
|
| Nonclinical model for assessing gastric effects of bisphosphonates. | 1997-02 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:32:41 GMT 2025
by
admin
on
Mon Mar 31 21:32:41 GMT 2025
|
| Record UNII |
ADD4H8T3K9
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2136
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
||
|
NCI_THESAURUS |
C67439
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
||
|
NCI_THESAURUS |
C443
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
75755-07-6
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
PRIMARY | |||
|
57637
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
PRIMARY | |||
|
SUB09912MIG
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
PRIMARY | |||
|
C66420
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
PRIMARY | |||
|
DTXSID50226652
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
PRIMARY | |||
|
6043
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
PRIMARY | |||
|
CHEMBL99369
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
PRIMARY | |||
|
ADD4H8T3K9
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
PRIMARY | |||
|
100000081667
Created by
admin on Mon Mar 31 21:32:41 GMT 2025 , Edited by admin on Mon Mar 31 21:32:41 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |